New COVID booster STX-S enters early human safety trial
NCT ID NCT07095231
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 29 times
Summary
This early-stage study tests a new booster vaccine, STX-S, in 60 healthy adults who have already had their primary COVID-19 shots and at least one booster. The goal is to check if different doses are safe and how well they boost the body's immune defenses against the virus. Participants receive a single injection and are monitored for side effects and immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, 98101-1466, United States
-
The University of Washington - Virology Research Clinic
Seattle, Washington, 98104, United States
-
University of Rochester Medical Center - Vaccine Research Unit
Rochester, New York, 14642-0001, United States
Conditions
Explore the condition pages connected to this study.